Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126628892 | 12662889 | 2 | F | 20100607 | 20160729 | 20160818 | 20160830 | EXP | GB-009507513-1009GBR00110 | MERCK | 56.00 | YR | M | Y | 0.00000 | 20160830 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126628892 | 12662889 | 1 | PS | EZETIMIBE. | EZETIMIBE | 1 | Oral | 10 MG, UNK | Y | 21445 | 10 | MG | TABLET | ||||||
| 126628892 | 12662889 | 2 | I | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 20 MG, UNKNOWN | Y | 0 | 20 | MG | |||||||
| 126628892 | 12662889 | 3 | I | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | 3 MG, UNKNOWN | Y | 0 | 3 | MG | TABLET | ||||||
| 126628892 | 12662889 | 4 | I | PERINDOPRIL | PERINDOPRIL | 1 | Unknown | 4 MG, UNKNOWN | Y | 0 | 4 | MG | |||||||
| 126628892 | 12662889 | 5 | I | RANITIDINE. | RANITIDINE | 1 | Unknown | 150 MG, BID | Y | 0 | 150 | MG | SYRUP | BID | |||||
| 126628892 | 12662889 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 75 MG, UNK | 0 | 75 | MG | TABLET | |||||||
| 126628892 | 12662889 | 7 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 126628892 | 12662889 | 8 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | Sublingual | 2 DF, UNK | 0 | 2 | DF | ||||||||
| 126628892 | 12662889 | 9 | C | GLYCOR | 2 | 0 | |||||||||||||
| 126628892 | 12662889 | 10 | C | TROLNITRATE PHOSPHATE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126628892 | 12662889 | 1 | Product used for unknown indication |
| 126628892 | 12662889 | 2 | Cerebrovascular accident prophylaxis |
| 126628892 | 12662889 | 3 | Cerebrovascular accident prophylaxis |
| 126628892 | 12662889 | 4 | Cerebrovascular accident prophylaxis |
| 126628892 | 12662889 | 5 | Cerebrovascular accident prophylaxis |
| 126628892 | 12662889 | 6 | Product used for unknown indication |
| 126628892 | 12662889 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126628892 | 12662889 | HO |
| 126628892 | 12662889 | LT |
| 126628892 | 12662889 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126628892 | 12662889 | Drug interaction | |
| 126628892 | 12662889 | Hypotension | |
| 126628892 | 12662889 | Stevens-Johnson syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126628892 | 12662889 | 1 | 2010 | 0 | ||
| 126628892 | 12662889 | 2 | 2010 | 0 | ||
| 126628892 | 12662889 | 3 | 2010 | 0 | ||
| 126628892 | 12662889 | 4 | 2010 | 0 | ||
| 126628892 | 12662889 | 5 | 2010 | 0 |